Macular edema is the most important cause of vision loss at the disease such as diabetic retinopathy, retinal vein root or branch occlusion, age related macular degeneration and uveitis. In our study, the findings from 50 eyes of 46 patients with the implementation of one dose intravitreal dexamethasone (IVD) diagnosed of retinal vein root or branch occlusion, diabetic retinopathy and macular edema related to non-enfective posterior uveitis, followed up at least 6 months after injection were evaluated retrospectively.Patients were evaluated of best corrected visual acuity (BCVA) and central macular thickness (CMT) before injection and 7th day, 1th, 2nd, 3th and 6th months after injection.All patients mean CMT and BCVA outcomes were compared before injection with 7th day, 1th, 2nd, 3th and 6th months after injection and the results were statistically significant (p
Key words: Intravitreal dexamethasone implant, macular edema, BCVA, CMT
|
